PTSD Checklist for DSM-5 (PCL-5)

The PCL-5 is a 20-item self-report measure that scores DSM-5 PTSD symptoms from 0-80 over the past month, in reference to a specific traumatic event. A total score of roughly 31-33 is commonly used as a provisional-PTSD screening threshold, though optimal cutoffs vary by setting and the tool does not replace a clinical diagnostic interview.

What the PCL-5 Measures

The PCL-5 was developed by the National Center for PTSD to track the 20 symptoms of posttraumatic stress disorder as defined in DSM-5, organized across four symptom clusters: intrusion (unwanted memories, flashbacks, distressing dreams), avoidance (of trauma-related thoughts, feelings, or reminders), negative alterations in cognition and mood (distorted blame, persistent negative beliefs, detachment, diminished interest), and alterations in arousal and reactivity (hypervigilance, irritability, exaggerated startle, sleep disturbance, concentration problems). Each item is rated on a 0 ("not at all") to 4 ("extremely") scale, and the instrument is anchored to a specific identified traumatic event rather than trauma exposure in general.

In concussion and post-injury care, the PCL-5 is relevant whenever the mechanism of injury itself was traumatic — motor vehicle collisions, assaults, falls, or combat and blast exposure are the most common examples. Traumatic brain injury and PTSD frequently co-occur and share overlapping symptoms (concentration difficulty, sleep disruption, irritability, avoidance of activity), which makes structured screening more useful than relying on unprompted patient disclosure.

Administration Time

The PCL-5 typically takes 5-10 minutes for a patient to complete as a self-report questionnaire. It can be administered on paper, verbally, or through a digital/patient-portal format, and requires no specialized examiner training to administer, though interpretation and any diagnostic follow-up should involve a qualified clinician.

Scoring and Interpretation

The PCL-5 produces a total symptom severity score ranging from 0 to 80, calculated as the sum of the 20 item ratings. It can also be scored by DSM-5 symptom cluster to see which symptom domains are driving the total.

A total score of approximately 31-33 is the cutoff most frequently cited in the general and veteran populations (per the National Center for PTSD) as suggestive of a provisional PTSD diagnosis warranting further clinical evaluation. However, this is not a fixed diagnostic line: validation research on the PCL-5 shows optimal cutoffs shift by population — sometimes as low as the high-20s in primary-care settings and higher in some trauma-specialty settings. The PCL-5 also supports DSM-5 symptom-cluster scoring rules for those who want a provisional diagnosis approximation rather than relying on the total score alone; see the scoring and interpretation guidance from Comorbidity Guidelines for the cluster-based rules.

For serial monitoring — the more common use case in a between-visit RTM workflow — a change of 5 points or more from a prior administration is generally treated as a clinically meaningful shift, in either direction. This makes the PCL-5 well suited to tracking trajectory over weeks of recovery rather than functioning only as a one-time screen.

Because the PCL-5 is a self-report screening tool, a positive score should prompt clinical interview or referral rather than stand alone as a diagnosis. The Clinician-Administered PTSD Scale (CAPS-5) is the structured-interview standard the PCL-5 is typically paired with when a formal diagnosis is being considered.

Clinical Use Case

In specialty practices treating post-injury patients, the PCL-5 is most useful in three situations: initial screening after a traumatically caused injury (to flag comorbid PTSD symptoms early, before they compound recovery), serial monitoring between visits (to catch symptom escalation or improvement without waiting for the next in-person appointment), and pre-referral documentation (to support a decision to refer to psychiatry, psychology, or trauma-focused therapy with objective, dated symptom data). It's also useful in return-to-work and return-to-learn planning, since untreated PTSD symptoms can slow functional recovery independent of the physical injury.

Billing: Which CPT Code Covers PCL-5 Administration

This page provides general educational information about CPT and RTM billing codes. It is not coding advice, a guarantee of reimbursement, or a substitute for your own compliance review. Payer coverage and documentation requirements vary by plan and can change — verify current requirements with CMS, your Medicare Administrative Contractor, and each payer before billing.

When the PCL-5 is administered and scored as a standalone brief standardized instrument, it is generally reported under 96127 (brief emotional/behavioral assessment with standardized instrument, scoring and documentation). When it is administered as one component of a larger structured psychological or neuropsychological evaluation, it may instead fall under the broader testing-administration codes — 96136/96137 (physician/QHP administration and scoring) or 96138/96139 (technician administration and scoring) — with the interpretive and integrative work captured under 96132/96133. Which pathway applies depends on who administers the instrument, how much time is spent, and whether it's billed in isolation or as part of a battery — consult the CMS billing and coding article on psychological and neuropsychological testing and your payer's current policy before selecting a code.

When the PCL-5 is captured as part of ongoing between-visit monitoring rather than a single in-office administration, that monitoring activity may separately support Remote Therapeutic Monitoring codes, since RTM specifically covers device-supplied data collection and review for behavioral health and musculoskeletal status between visits.

Where PCL-5 Sits in the Kavera Protocol

The PCL-5 is one of the mood/anxiety/PTSD screens included in Kavera's assessment battery, and it sits primarily within the Mental Health module, with cross-relevance to the Concussion module whenever the injury mechanism was traumatic. It is typically deployed alongside other screens such as the PHQ-9 and GAD-7 so that mood, anxiety, and trauma-related symptoms are monitored together rather than in isolation, giving the treating clinician a fuller comorbidity picture between visits.

How Kavera Handles This

The PCL-5 is part of the first-visit neuropsych battery for every concussion patient and repeats on your cadence in the Mental Health module. Kavera scores it, flags the 31–33 cutoff, and plots it next to PHQ-9 and PSQI so trauma symptoms after injury show up before the patient mentions them. Self-Serve practices run this with their own staff. On Managed, our team runs it and bills it under your credentials.